Go to the main content area
:::
Open a new window go to facebook
Open a new window go to youtube
Sign in
Sign in
Newsletter
Language
繁體中文
日本語
Site Map
News
Database
Startup Ecosystem
Investment Deals
Startups
Investors
Research
About
Search
Search
Menu
Search
Close menu
News
Database
Startup Ecosystem
Investment Deals
Startups
Investors
Research
Events
About Us
Open a new window go to facebook
Open a new window go to youtube
Database
:::
Home
Database
Startups
BRIM BIOTECHNOLOGY, INC.
Startups
BRIM BIOTECHNOLOGY, INC.
Update:2026/03/31
Industries
Biotechnology
Biopharma
Medical
Pharmaceutical
Share
Share on Facebook
Share on Line
Share on Linkedin
Share on twitter
Add to Favorites
Edit
Fill out the questionnaire
About
Financials
Patent
News
Title
Date
全福結盟亞果生醫、斥1.5億重押康百事!林羣策略佈局在想什麼?
2025/09
全福斥1.5億入股康百事持股達42% 強化新藥開發、精準醫療發展
2025/09
全福生技青光眼新藥BRM411 獲邀國際青光眼研究協會年會發表
2024/11
生技股添新兵! 全福、邦睿上市案獲證交所董事會通過;賽諾菲2700萬美元入股Ventyx 獲心血管、神經退化性疾病候選新藥獨佔談判權
2024/09
全福上市申請案 通過證交所審議
2024/09
上市青光眼藥發明人林鄭文 轉戰全福技術長衝刺兩滴劑新藥
2024/09
全福技轉、新藥臨床雙軌並進 今年Q3啟動上市申請
2024/06
全福生技斥4億元獲信力、碩德臨床階段眼藥水授權
2024/06
BRIM Biotechnology, Inc. announced its three focus areas for this year's operations
2024/02
BRIM Biotech facilitated the enrollment for a Phase III clinical trial of their dry eye disease drug
2023/12
BRIM Biotechnology, Inc. ’s dry eye drug missed the primary goal in its late-stage trial
2023/12
杜克大學Victor L. Perez來台:乾眼症成因複雜 GVHD揭眼部發炎機制
2023/10
永立榮羊水幹細胞新藥治勃起障礙獲准在臺試驗;先驅攜BioCina合作CAR-T臨床一期;再生元單抗藥兒童三期試驗達標;UCSD藻類發光水凝膠可望成藥物載體;全福將辦國際前眼症研討會
2023/10
全福乾眼症新藥 獲中國NMPA准進2期臨床
2023/04
全福乾眼新藥臨床三期成功在美收案
2023/03
全福生技結盟國際眼科CRO公司Ora 加速乾眼症新藥三期臨床
2022/05
創新技術拼場 「投資媒合擂台」免疫功坊、全福、三喬、矽基、路明思勝出
2022/04
簡海珊:「推動孤兒藥開發,營造醫病雙贏策略」
2021/09
全福跨國顧問團分享藥物開發核心能量
2017/10